drugset / Trial / NCT00645151

A Study Of The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High Cholesterol

NCT00645151 ↗

Phase 4 Completed 512 enrolled Viatris Inc.
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the percentage of patients who would reach a cholesterol goal after atorvastatin treatment.

Timeline

Start
2004-04
Primary completion
—
Completion
2005-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 10 mg —
Subject Atorvastatin Small molecule 20 mg —
Subject Atorvastatin Small molecule 40 mg —
Subject Atorvastatin Small molecule 80 mg —

Indications